Global Dry Age-Related Macular Degeneration Market Research Report 2024(Status and Outlook)
![](/report_cover/11711/global-dry-age-related-macular-degeneration-market-research-report-2024status-n-outlook_en.gif)
Report Overview:
Dry macular degeneration is a common eye disorder among people over 50. It causes blurred or reduced central vision, due to thinning of the macula (MAK-u-luh). The macula is the part of the retina responsible for clear vision in your direct line of sight.
The Global Dry Age-Related Macular Degeneration Market Size was estimated at USD 1475.12 million in 2023 and is projected to reach USD 2152.41 million by 2029, exhibiting a CAGR of 6.50% during the forecast period.
This report provides a deep insight into the global Dry Age-Related Macular Degeneration market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Dry Age-Related Macular Degeneration Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Dry Age-Related Macular Degeneration market in any manner.
Global Dry Age-Related Macular Degeneration Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Santen Pharmaceuticals
Allergan
Bausch Health
Alimera Science
Phio Pharmaceuticals
Ocumension Therapeutics
Belite Bio
Kubota Vision
Iveric Bio
Eyestem Research
Y2 Solution
Stealth Biotherapeutics
Market Segmentation (by Type)
Oral
Injectables
Market Segmentation (by Application)
Above 40 Years
Above 60 Years
Above 75 Years
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Dry Age-Related Macular Degeneration Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Dry macular degeneration is a common eye disorder among people over 50. It causes blurred or reduced central vision, due to thinning of the macula (MAK-u-luh). The macula is the part of the retina responsible for clear vision in your direct line of sight.
The Global Dry Age-Related Macular Degeneration Market Size was estimated at USD 1475.12 million in 2023 and is projected to reach USD 2152.41 million by 2029, exhibiting a CAGR of 6.50% during the forecast period.
This report provides a deep insight into the global Dry Age-Related Macular Degeneration market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Dry Age-Related Macular Degeneration Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Dry Age-Related Macular Degeneration market in any manner.
Global Dry Age-Related Macular Degeneration Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Santen Pharmaceuticals
Allergan
Bausch Health
Alimera Science
Phio Pharmaceuticals
Ocumension Therapeutics
Belite Bio
Kubota Vision
Iveric Bio
Eyestem Research
Y2 Solution
Stealth Biotherapeutics
Market Segmentation (by Type)
Oral
Injectables
Market Segmentation (by Application)
Above 40 Years
Above 60 Years
Above 75 Years
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Dry Age-Related Macular Degeneration Market
- Overview of the regional outlook of the Dry Age-Related Macular Degeneration Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Dry Age-Related Macular Degeneration Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Dry Age-Related Macular Degeneration
1.2 Key Market Segments
1.2.1 Dry Age-Related Macular Degeneration Segment by Type
1.2.2 Dry Age-Related Macular Degeneration Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DRY AGE-RELATED MACULAR DEGENERATION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Dry Age-Related Macular Degeneration Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Dry Age-Related Macular Degeneration Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DRY AGE-RELATED MACULAR DEGENERATION MARKET COMPETITIVE LANDSCAPE
3.1 Global Dry Age-Related Macular Degeneration Sales by Manufacturers (2019-2024)
3.2 Global Dry Age-Related Macular Degeneration Revenue Market Share by Manufacturers (2019-2024)
3.3 Dry Age-Related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Dry Age-Related Macular Degeneration Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Dry Age-Related Macular Degeneration Sales Sites, Area Served, Product Type
3.6 Dry Age-Related Macular Degeneration Market Competitive Situation and Trends
3.6.1 Dry Age-Related Macular Degeneration Market Concentration Rate
3.6.2 Global 5 and 10 Largest Dry Age-Related Macular Degeneration Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 DRY AGE-RELATED MACULAR DEGENERATION INDUSTRY CHAIN ANALYSIS
4.1 Dry Age-Related Macular Degeneration Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DRY AGE-RELATED MACULAR DEGENERATION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 DRY AGE-RELATED MACULAR DEGENERATION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Dry Age-Related Macular Degeneration Sales Market Share by Type (2019-2024)
6.3 Global Dry Age-Related Macular Degeneration Market Size Market Share by Type (2019-2024)
6.4 Global Dry Age-Related Macular Degeneration Price by Type (2019-2024)
7 DRY AGE-RELATED MACULAR DEGENERATION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Dry Age-Related Macular Degeneration Market Sales by Application (2019-2024)
7.3 Global Dry Age-Related Macular Degeneration Market Size (M USD) by Application (2019-2024)
7.4 Global Dry Age-Related Macular Degeneration Sales Growth Rate by Application (2019-2024)
8 DRY AGE-RELATED MACULAR DEGENERATION MARKET SEGMENTATION BY REGION
8.1 Global Dry Age-Related Macular Degeneration Sales by Region
8.1.1 Global Dry Age-Related Macular Degeneration Sales by Region
8.1.2 Global Dry Age-Related Macular Degeneration Sales Market Share by Region
8.2 North America
8.2.1 North America Dry Age-Related Macular Degeneration Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Dry Age-Related Macular Degeneration Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Dry Age-Related Macular Degeneration Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Dry Age-Related Macular Degeneration Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Dry Age-Related Macular Degeneration Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Santen Pharmaceuticals
9.1.1 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Basic Information
9.1.2 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product Overview
9.1.3 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product Market Performance
9.1.4 Santen Pharmaceuticals Business Overview
9.1.5 Santen Pharmaceuticals Dry Age-Related Macular Degeneration SWOT Analysis
9.1.6 Santen Pharmaceuticals Recent Developments
9.2 Allergan
9.2.1 Allergan Dry Age-Related Macular Degeneration Basic Information
9.2.2 Allergan Dry Age-Related Macular Degeneration Product Overview
9.2.3 Allergan Dry Age-Related Macular Degeneration Product Market Performance
9.2.4 Allergan Business Overview
9.2.5 Allergan Dry Age-Related Macular Degeneration SWOT Analysis
9.2.6 Allergan Recent Developments
9.3 Bausch Health
9.3.1 Bausch Health Dry Age-Related Macular Degeneration Basic Information
9.3.2 Bausch Health Dry Age-Related Macular Degeneration Product Overview
9.3.3 Bausch Health Dry Age-Related Macular Degeneration Product Market Performance
9.3.4 Bausch Health Dry Age-Related Macular Degeneration SWOT Analysis
9.3.5 Bausch Health Business Overview
9.3.6 Bausch Health Recent Developments
9.4 Alimera Science
9.4.1 Alimera Science Dry Age-Related Macular Degeneration Basic Information
9.4.2 Alimera Science Dry Age-Related Macular Degeneration Product Overview
9.4.3 Alimera Science Dry Age-Related Macular Degeneration Product Market Performance
9.4.4 Alimera Science Business Overview
9.4.5 Alimera Science Recent Developments
9.5 Phio Pharmaceuticals
9.5.1 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Basic Information
9.5.2 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product Overview
9.5.3 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product Market Performance
9.5.4 Phio Pharmaceuticals Business Overview
9.5.5 Phio Pharmaceuticals Recent Developments
9.6 Ocumension Therapeutics
9.6.1 Ocumension Therapeutics Dry Age-Related Macular Degeneration Basic Information
9.6.2 Ocumension Therapeutics Dry Age-Related Macular Degeneration Product Overview
9.6.3 Ocumension Therapeutics Dry Age-Related Macular Degeneration Product Market Performance
9.6.4 Ocumension Therapeutics Business Overview
9.6.5 Ocumension Therapeutics Recent Developments
9.7 Belite Bio
9.7.1 Belite Bio Dry Age-Related Macular Degeneration Basic Information
9.7.2 Belite Bio Dry Age-Related Macular Degeneration Product Overview
9.7.3 Belite Bio Dry Age-Related Macular Degeneration Product Market Performance
9.7.4 Belite Bio Business Overview
9.7.5 Belite Bio Recent Developments
9.8 Kubota Vision
9.8.1 Kubota Vision Dry Age-Related Macular Degeneration Basic Information
9.8.2 Kubota Vision Dry Age-Related Macular Degeneration Product Overview
9.8.3 Kubota Vision Dry Age-Related Macular Degeneration Product Market Performance
9.8.4 Kubota Vision Business Overview
9.8.5 Kubota Vision Recent Developments
9.9 Iveric Bio
9.9.1 Iveric Bio Dry Age-Related Macular Degeneration Basic Information
9.9.2 Iveric Bio Dry Age-Related Macular Degeneration Product Overview
9.9.3 Iveric Bio Dry Age-Related Macular Degeneration Product Market Performance
9.9.4 Iveric Bio Business Overview
9.9.5 Iveric Bio Recent Developments
9.10 Eyestem Research
9.10.1 Eyestem Research Dry Age-Related Macular Degeneration Basic Information
9.10.2 Eyestem Research Dry Age-Related Macular Degeneration Product Overview
9.10.3 Eyestem Research Dry Age-Related Macular Degeneration Product Market Performance
9.10.4 Eyestem Research Business Overview
9.10.5 Eyestem Research Recent Developments
9.11 Y2 Solution
9.11.1 Y2 Solution Dry Age-Related Macular Degeneration Basic Information
9.11.2 Y2 Solution Dry Age-Related Macular Degeneration Product Overview
9.11.3 Y2 Solution Dry Age-Related Macular Degeneration Product Market Performance
9.11.4 Y2 Solution Business Overview
9.11.5 Y2 Solution Recent Developments
9.12 Stealth Biotherapeutics
9.12.1 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Basic Information
9.12.2 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product Overview
9.12.3 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product Market Performance
9.12.4 Stealth Biotherapeutics Business Overview
9.12.5 Stealth Biotherapeutics Recent Developments
10 DRY AGE-RELATED MACULAR DEGENERATION MARKET FORECAST BY REGION
10.1 Global Dry Age-Related Macular Degeneration Market Size Forecast
10.2 Global Dry Age-Related Macular Degeneration Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Dry Age-Related Macular Degeneration Market Size Forecast by Country
10.2.3 Asia Pacific Dry Age-Related Macular Degeneration Market Size Forecast by Region
10.2.4 South America Dry Age-Related Macular Degeneration Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Dry Age-Related Macular Degeneration by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Dry Age-Related Macular Degeneration Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Dry Age-Related Macular Degeneration by Type (2025-2030)
11.1.2 Global Dry Age-Related Macular Degeneration Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Dry Age-Related Macular Degeneration by Type (2025-2030)
11.2 Global Dry Age-Related Macular Degeneration Market Forecast by Application (2025-2030)
11.2.1 Global Dry Age-Related Macular Degeneration Sales (Kilotons) Forecast by Application
11.2.2 Global Dry Age-Related Macular Degeneration Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Dry Age-Related Macular Degeneration
1.2 Key Market Segments
1.2.1 Dry Age-Related Macular Degeneration Segment by Type
1.2.2 Dry Age-Related Macular Degeneration Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DRY AGE-RELATED MACULAR DEGENERATION MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Dry Age-Related Macular Degeneration Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Dry Age-Related Macular Degeneration Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DRY AGE-RELATED MACULAR DEGENERATION MARKET COMPETITIVE LANDSCAPE
3.1 Global Dry Age-Related Macular Degeneration Sales by Manufacturers (2019-2024)
3.2 Global Dry Age-Related Macular Degeneration Revenue Market Share by Manufacturers (2019-2024)
3.3 Dry Age-Related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Dry Age-Related Macular Degeneration Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Dry Age-Related Macular Degeneration Sales Sites, Area Served, Product Type
3.6 Dry Age-Related Macular Degeneration Market Competitive Situation and Trends
3.6.1 Dry Age-Related Macular Degeneration Market Concentration Rate
3.6.2 Global 5 and 10 Largest Dry Age-Related Macular Degeneration Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 DRY AGE-RELATED MACULAR DEGENERATION INDUSTRY CHAIN ANALYSIS
4.1 Dry Age-Related Macular Degeneration Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DRY AGE-RELATED MACULAR DEGENERATION MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 DRY AGE-RELATED MACULAR DEGENERATION MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Dry Age-Related Macular Degeneration Sales Market Share by Type (2019-2024)
6.3 Global Dry Age-Related Macular Degeneration Market Size Market Share by Type (2019-2024)
6.4 Global Dry Age-Related Macular Degeneration Price by Type (2019-2024)
7 DRY AGE-RELATED MACULAR DEGENERATION MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Dry Age-Related Macular Degeneration Market Sales by Application (2019-2024)
7.3 Global Dry Age-Related Macular Degeneration Market Size (M USD) by Application (2019-2024)
7.4 Global Dry Age-Related Macular Degeneration Sales Growth Rate by Application (2019-2024)
8 DRY AGE-RELATED MACULAR DEGENERATION MARKET SEGMENTATION BY REGION
8.1 Global Dry Age-Related Macular Degeneration Sales by Region
8.1.1 Global Dry Age-Related Macular Degeneration Sales by Region
8.1.2 Global Dry Age-Related Macular Degeneration Sales Market Share by Region
8.2 North America
8.2.1 North America Dry Age-Related Macular Degeneration Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Dry Age-Related Macular Degeneration Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Dry Age-Related Macular Degeneration Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Dry Age-Related Macular Degeneration Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Dry Age-Related Macular Degeneration Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Santen Pharmaceuticals
9.1.1 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Basic Information
9.1.2 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product Overview
9.1.3 Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product Market Performance
9.1.4 Santen Pharmaceuticals Business Overview
9.1.5 Santen Pharmaceuticals Dry Age-Related Macular Degeneration SWOT Analysis
9.1.6 Santen Pharmaceuticals Recent Developments
9.2 Allergan
9.2.1 Allergan Dry Age-Related Macular Degeneration Basic Information
9.2.2 Allergan Dry Age-Related Macular Degeneration Product Overview
9.2.3 Allergan Dry Age-Related Macular Degeneration Product Market Performance
9.2.4 Allergan Business Overview
9.2.5 Allergan Dry Age-Related Macular Degeneration SWOT Analysis
9.2.6 Allergan Recent Developments
9.3 Bausch Health
9.3.1 Bausch Health Dry Age-Related Macular Degeneration Basic Information
9.3.2 Bausch Health Dry Age-Related Macular Degeneration Product Overview
9.3.3 Bausch Health Dry Age-Related Macular Degeneration Product Market Performance
9.3.4 Bausch Health Dry Age-Related Macular Degeneration SWOT Analysis
9.3.5 Bausch Health Business Overview
9.3.6 Bausch Health Recent Developments
9.4 Alimera Science
9.4.1 Alimera Science Dry Age-Related Macular Degeneration Basic Information
9.4.2 Alimera Science Dry Age-Related Macular Degeneration Product Overview
9.4.3 Alimera Science Dry Age-Related Macular Degeneration Product Market Performance
9.4.4 Alimera Science Business Overview
9.4.5 Alimera Science Recent Developments
9.5 Phio Pharmaceuticals
9.5.1 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Basic Information
9.5.2 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product Overview
9.5.3 Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product Market Performance
9.5.4 Phio Pharmaceuticals Business Overview
9.5.5 Phio Pharmaceuticals Recent Developments
9.6 Ocumension Therapeutics
9.6.1 Ocumension Therapeutics Dry Age-Related Macular Degeneration Basic Information
9.6.2 Ocumension Therapeutics Dry Age-Related Macular Degeneration Product Overview
9.6.3 Ocumension Therapeutics Dry Age-Related Macular Degeneration Product Market Performance
9.6.4 Ocumension Therapeutics Business Overview
9.6.5 Ocumension Therapeutics Recent Developments
9.7 Belite Bio
9.7.1 Belite Bio Dry Age-Related Macular Degeneration Basic Information
9.7.2 Belite Bio Dry Age-Related Macular Degeneration Product Overview
9.7.3 Belite Bio Dry Age-Related Macular Degeneration Product Market Performance
9.7.4 Belite Bio Business Overview
9.7.5 Belite Bio Recent Developments
9.8 Kubota Vision
9.8.1 Kubota Vision Dry Age-Related Macular Degeneration Basic Information
9.8.2 Kubota Vision Dry Age-Related Macular Degeneration Product Overview
9.8.3 Kubota Vision Dry Age-Related Macular Degeneration Product Market Performance
9.8.4 Kubota Vision Business Overview
9.8.5 Kubota Vision Recent Developments
9.9 Iveric Bio
9.9.1 Iveric Bio Dry Age-Related Macular Degeneration Basic Information
9.9.2 Iveric Bio Dry Age-Related Macular Degeneration Product Overview
9.9.3 Iveric Bio Dry Age-Related Macular Degeneration Product Market Performance
9.9.4 Iveric Bio Business Overview
9.9.5 Iveric Bio Recent Developments
9.10 Eyestem Research
9.10.1 Eyestem Research Dry Age-Related Macular Degeneration Basic Information
9.10.2 Eyestem Research Dry Age-Related Macular Degeneration Product Overview
9.10.3 Eyestem Research Dry Age-Related Macular Degeneration Product Market Performance
9.10.4 Eyestem Research Business Overview
9.10.5 Eyestem Research Recent Developments
9.11 Y2 Solution
9.11.1 Y2 Solution Dry Age-Related Macular Degeneration Basic Information
9.11.2 Y2 Solution Dry Age-Related Macular Degeneration Product Overview
9.11.3 Y2 Solution Dry Age-Related Macular Degeneration Product Market Performance
9.11.4 Y2 Solution Business Overview
9.11.5 Y2 Solution Recent Developments
9.12 Stealth Biotherapeutics
9.12.1 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Basic Information
9.12.2 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product Overview
9.12.3 Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product Market Performance
9.12.4 Stealth Biotherapeutics Business Overview
9.12.5 Stealth Biotherapeutics Recent Developments
10 DRY AGE-RELATED MACULAR DEGENERATION MARKET FORECAST BY REGION
10.1 Global Dry Age-Related Macular Degeneration Market Size Forecast
10.2 Global Dry Age-Related Macular Degeneration Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Dry Age-Related Macular Degeneration Market Size Forecast by Country
10.2.3 Asia Pacific Dry Age-Related Macular Degeneration Market Size Forecast by Region
10.2.4 South America Dry Age-Related Macular Degeneration Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Dry Age-Related Macular Degeneration by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Dry Age-Related Macular Degeneration Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Dry Age-Related Macular Degeneration by Type (2025-2030)
11.1.2 Global Dry Age-Related Macular Degeneration Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Dry Age-Related Macular Degeneration by Type (2025-2030)
11.2 Global Dry Age-Related Macular Degeneration Market Forecast by Application (2025-2030)
11.2.1 Global Dry Age-Related Macular Degeneration Sales (Kilotons) Forecast by Application
11.2.2 Global Dry Age-Related Macular Degeneration Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Dry Age-Related Macular Degeneration Market Size Comparison by Region (M USD)
Table 5. Global Dry Age-Related Macular Degeneration Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Dry Age-Related Macular Degeneration Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Dry Age-Related Macular Degeneration Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Dry Age-Related Macular Degeneration Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Age-Related Macular Degeneration as of 2022)
Table 10. Global Market Dry Age-Related Macular Degeneration Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Dry Age-Related Macular Degeneration Sales Sites and Area Served
Table 12. Manufacturers Dry Age-Related Macular Degeneration Product Type
Table 13. Global Dry Age-Related Macular Degeneration Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Dry Age-Related Macular Degeneration
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Dry Age-Related Macular Degeneration Market Challenges
Table 22. Global Dry Age-Related Macular Degeneration Sales by Type (Kilotons)
Table 23. Global Dry Age-Related Macular Degeneration Market Size by Type (M USD)
Table 24. Global Dry Age-Related Macular Degeneration Sales (Kilotons) by Type (2019-2024)
Table 25. Global Dry Age-Related Macular Degeneration Sales Market Share by Type (2019-2024)
Table 26. Global Dry Age-Related Macular Degeneration Market Size (M USD) by Type (2019-2024)
Table 27. Global Dry Age-Related Macular Degeneration Market Size Share by Type (2019-2024)
Table 28. Global Dry Age-Related Macular Degeneration Price (USD/Ton) by Type (2019-2024)
Table 29. Global Dry Age-Related Macular Degeneration Sales (Kilotons) by Application
Table 30. Global Dry Age-Related Macular Degeneration Market Size by Application
Table 31. Global Dry Age-Related Macular Degeneration Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Dry Age-Related Macular Degeneration Sales Market Share by Application (2019-2024)
Table 33. Global Dry Age-Related Macular Degeneration Sales by Application (2019-2024) & (M USD)
Table 34. Global Dry Age-Related Macular Degeneration Market Share by Application (2019-2024)
Table 35. Global Dry Age-Related Macular Degeneration Sales Growth Rate by Application (2019-2024)
Table 36. Global Dry Age-Related Macular Degeneration Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Dry Age-Related Macular Degeneration Sales Market Share by Region (2019-2024)
Table 38. North America Dry Age-Related Macular Degeneration Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Dry Age-Related Macular Degeneration Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Dry Age-Related Macular Degeneration Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Dry Age-Related Macular Degeneration Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Dry Age-Related Macular Degeneration Sales by Region (2019-2024) & (Kilotons)
Table 43. Santen Pharmaceuticals Dry Age-Related Macular Degeneration Basic Information
Table 44. Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product Overview
Table 45. Santen Pharmaceuticals Dry Age-Related Macular Degeneration Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Santen Pharmaceuticals Business Overview
Table 47. Santen Pharmaceuticals Dry Age-Related Macular Degeneration SWOT Analysis
Table 48. Santen Pharmaceuticals Recent Developments
Table 49. Allergan Dry Age-Related Macular Degeneration Basic Information
Table 50. Allergan Dry Age-Related Macular Degeneration Product Overview
Table 51. Allergan Dry Age-Related Macular Degeneration Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Allergan Business Overview
Table 53. Allergan Dry Age-Related Macular Degeneration SWOT Analysis
Table 54. Allergan Recent Developments
Table 55. Bausch Health Dry Age-Related Macular Degeneration Basic Information
Table 56. Bausch Health Dry Age-Related Macular Degeneration Product Overview
Table 57. Bausch Health Dry Age-Related Macular Degeneration Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Bausch Health Dry Age-Related Macular Degeneration SWOT Analysis
Table 59. Bausch Health Business Overview
Table 60. Bausch Health Recent Developments
Table 61. Alimera Science Dry Age-Related Macular Degeneration Basic Information
Table 62. Alimera Science Dry Age-Related Macular Degeneration Product Overview
Table 63. Alimera Science Dry Age-Related Macular Degeneration Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Alimera Science Business Overview
Table 65. Alimera Science Recent Developments
Table 66. Phio Pharmaceuticals Dry Age-Related Macular Degeneration Basic Information
Table 67. Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product Overview
Table 68. Phio Pharmaceuticals Dry Age-Related Macular Degeneration Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Phio Pharmaceuticals Business Overview
Table 70. Phio Pharmaceuticals Recent Developments
Table 71. Ocumension Therapeutics Dry Age-Related Macular Degeneration Basic Information
Table 72. Ocumension Therapeutics Dry Age-Related Macular Degeneration Product Overview
Table 73. Ocumension Therapeutics Dry Age-Related Macular Degeneration Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Ocumension Therapeutics Business Overview
Table 75. Ocumension Therapeutics Recent Developments
Table 76. Belite Bio Dry Age-Related Macular Degeneration Basic Information
Table 77. Belite Bio Dry Age-Related Macular Degeneration Product Overview
Table 78. Belite Bio Dry Age-Related Macular Degeneration Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Belite Bio Business Overview
Table 80. Belite Bio Recent Developments
Table 81. Kubota Vision Dry Age-Related Macular Degeneration Basic Information
Table 82. Kubota Vision Dry Age-Related Macular Degeneration Product Overview
Table 83. Kubota Vision Dry Age-Related Macular Degeneration Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Kubota Vision Business Overview
Table 85. Kubota Vision Recent Developments
Table 86. Iveric Bio Dry Age-Related Macular Degeneration Basic Information
Table 87. Iveric Bio Dry Age-Related Macular Degeneration Product Overview
Table 88. Iveric Bio Dry Age-Related Macular Degeneration Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Iveric Bio Business Overview
Table 90. Iveric Bio Recent Developments
Table 91. Eyestem Research Dry Age-Related Macular Degeneration Basic Information
Table 92. Eyestem Research Dry Age-Related Macular Degeneration Product Overview
Table 93. Eyestem Research Dry Age-Related Macular Degeneration Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Eyestem Research Business Overview
Table 95. Eyestem Research Recent Developments
Table 96. Y2 Solution Dry Age-Related Macular Degeneration Basic Information
Table 97. Y2 Solution Dry Age-Related Macular Degeneration Product Overview
Table 98. Y2 Solution Dry Age-Related Macular Degeneration Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Y2 Solution Business Overview
Table 100. Y2 Solution Recent Developments
Table 101. Stealth Biotherapeutics Dry Age-Related Macular Degeneration Basic Information
Table 102. Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product Overview
Table 103. Stealth Biotherapeutics Dry Age-Related Macular Degeneration Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Stealth Biotherapeutics Business Overview
Table 105. Stealth Biotherapeutics Recent Developments
Table 106. Global Dry Age-Related Macular Degeneration Sales Forecast by Region (2025-2030) & (Kilotons)
Table 107. Global Dry Age-Related Macular Degeneration Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Dry Age-Related Macular Degeneration Sales Forecast by Country (2025-2030) & (Kilotons)
Table 109. North America Dry Age-Related Macular Degeneration Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Dry Age-Related Macular Degeneration Sales Forecast by Country (2025-2030) & (Kilotons)
Table 111. Europe Dry Age-Related Macular Degeneration Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Dry Age-Related Macular Degeneration Sales Forecast by Region (2025-2030) & (Kilotons)
Table 113. Asia Pacific Dry Age-Related Macular Degeneration Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Dry Age-Related Macular Degeneration Sales Forecast by Country (2025-2030) & (Kilotons)
Table 115. South America Dry Age-Related Macular Degeneration Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Dry Age-Related Macular Degeneration Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Dry Age-Related Macular Degeneration Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Dry Age-Related Macular Degeneration Sales Forecast by Type (2025-2030) & (Kilotons)
Table 119. Global Dry Age-Related Macular Degeneration Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Dry Age-Related Macular Degeneration Price Forecast by Type (2025-2030) & (USD/Ton)
Table 121. Global Dry Age-Related Macular Degeneration Sales (Kilotons) Forecast by Application (2025-2030)
Table 122. Global Dry Age-Related Macular Degeneration Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Dry Age-Related Macular Degeneration Market Size Comparison by Region (M USD)
Table 5. Global Dry Age-Related Macular Degeneration Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Dry Age-Related Macular Degeneration Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Dry Age-Related Macular Degeneration Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Dry Age-Related Macular Degeneration Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Age-Related Macular Degeneration as of 2022)
Table 10. Global Market Dry Age-Related Macular Degeneration Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Dry Age-Related Macular Degeneration Sales Sites and Area Served
Table 12. Manufacturers Dry Age-Related Macular Degeneration Product Type
Table 13. Global Dry Age-Related Macular Degeneration Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Dry Age-Related Macular Degeneration
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Dry Age-Related Macular Degeneration Market Challenges
Table 22. Global Dry Age-Related Macular Degeneration Sales by Type (Kilotons)
Table 23. Global Dry Age-Related Macular Degeneration Market Size by Type (M USD)
Table 24. Global Dry Age-Related Macular Degeneration Sales (Kilotons) by Type (2019-2024)
Table 25. Global Dry Age-Related Macular Degeneration Sales Market Share by Type (2019-2024)
Table 26. Global Dry Age-Related Macular Degeneration Market Size (M USD) by Type (2019-2024)
Table 27. Global Dry Age-Related Macular Degeneration Market Size Share by Type (2019-2024)
Table 28. Global Dry Age-Related Macular Degeneration Price (USD/Ton) by Type (2019-2024)
Table 29. Global Dry Age-Related Macular Degeneration Sales (Kilotons) by Application
Table 30. Global Dry Age-Related Macular Degeneration Market Size by Application
Table 31. Global Dry Age-Related Macular Degeneration Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Dry Age-Related Macular Degeneration Sales Market Share by Application (2019-2024)
Table 33. Global Dry Age-Related Macular Degeneration Sales by Application (2019-2024) & (M USD)
Table 34. Global Dry Age-Related Macular Degeneration Market Share by Application (2019-2024)
Table 35. Global Dry Age-Related Macular Degeneration Sales Growth Rate by Application (2019-2024)
Table 36. Global Dry Age-Related Macular Degeneration Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Dry Age-Related Macular Degeneration Sales Market Share by Region (2019-2024)
Table 38. North America Dry Age-Related Macular Degeneration Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Dry Age-Related Macular Degeneration Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Dry Age-Related Macular Degeneration Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Dry Age-Related Macular Degeneration Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Dry Age-Related Macular Degeneration Sales by Region (2019-2024) & (Kilotons)
Table 43. Santen Pharmaceuticals Dry Age-Related Macular Degeneration Basic Information
Table 44. Santen Pharmaceuticals Dry Age-Related Macular Degeneration Product Overview
Table 45. Santen Pharmaceuticals Dry Age-Related Macular Degeneration Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Santen Pharmaceuticals Business Overview
Table 47. Santen Pharmaceuticals Dry Age-Related Macular Degeneration SWOT Analysis
Table 48. Santen Pharmaceuticals Recent Developments
Table 49. Allergan Dry Age-Related Macular Degeneration Basic Information
Table 50. Allergan Dry Age-Related Macular Degeneration Product Overview
Table 51. Allergan Dry Age-Related Macular Degeneration Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Allergan Business Overview
Table 53. Allergan Dry Age-Related Macular Degeneration SWOT Analysis
Table 54. Allergan Recent Developments
Table 55. Bausch Health Dry Age-Related Macular Degeneration Basic Information
Table 56. Bausch Health Dry Age-Related Macular Degeneration Product Overview
Table 57. Bausch Health Dry Age-Related Macular Degeneration Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Bausch Health Dry Age-Related Macular Degeneration SWOT Analysis
Table 59. Bausch Health Business Overview
Table 60. Bausch Health Recent Developments
Table 61. Alimera Science Dry Age-Related Macular Degeneration Basic Information
Table 62. Alimera Science Dry Age-Related Macular Degeneration Product Overview
Table 63. Alimera Science Dry Age-Related Macular Degeneration Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Alimera Science Business Overview
Table 65. Alimera Science Recent Developments
Table 66. Phio Pharmaceuticals Dry Age-Related Macular Degeneration Basic Information
Table 67. Phio Pharmaceuticals Dry Age-Related Macular Degeneration Product Overview
Table 68. Phio Pharmaceuticals Dry Age-Related Macular Degeneration Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Phio Pharmaceuticals Business Overview
Table 70. Phio Pharmaceuticals Recent Developments
Table 71. Ocumension Therapeutics Dry Age-Related Macular Degeneration Basic Information
Table 72. Ocumension Therapeutics Dry Age-Related Macular Degeneration Product Overview
Table 73. Ocumension Therapeutics Dry Age-Related Macular Degeneration Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Ocumension Therapeutics Business Overview
Table 75. Ocumension Therapeutics Recent Developments
Table 76. Belite Bio Dry Age-Related Macular Degeneration Basic Information
Table 77. Belite Bio Dry Age-Related Macular Degeneration Product Overview
Table 78. Belite Bio Dry Age-Related Macular Degeneration Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Belite Bio Business Overview
Table 80. Belite Bio Recent Developments
Table 81. Kubota Vision Dry Age-Related Macular Degeneration Basic Information
Table 82. Kubota Vision Dry Age-Related Macular Degeneration Product Overview
Table 83. Kubota Vision Dry Age-Related Macular Degeneration Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Kubota Vision Business Overview
Table 85. Kubota Vision Recent Developments
Table 86. Iveric Bio Dry Age-Related Macular Degeneration Basic Information
Table 87. Iveric Bio Dry Age-Related Macular Degeneration Product Overview
Table 88. Iveric Bio Dry Age-Related Macular Degeneration Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Iveric Bio Business Overview
Table 90. Iveric Bio Recent Developments
Table 91. Eyestem Research Dry Age-Related Macular Degeneration Basic Information
Table 92. Eyestem Research Dry Age-Related Macular Degeneration Product Overview
Table 93. Eyestem Research Dry Age-Related Macular Degeneration Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Eyestem Research Business Overview
Table 95. Eyestem Research Recent Developments
Table 96. Y2 Solution Dry Age-Related Macular Degeneration Basic Information
Table 97. Y2 Solution Dry Age-Related Macular Degeneration Product Overview
Table 98. Y2 Solution Dry Age-Related Macular Degeneration Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Y2 Solution Business Overview
Table 100. Y2 Solution Recent Developments
Table 101. Stealth Biotherapeutics Dry Age-Related Macular Degeneration Basic Information
Table 102. Stealth Biotherapeutics Dry Age-Related Macular Degeneration Product Overview
Table 103. Stealth Biotherapeutics Dry Age-Related Macular Degeneration Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Stealth Biotherapeutics Business Overview
Table 105. Stealth Biotherapeutics Recent Developments
Table 106. Global Dry Age-Related Macular Degeneration Sales Forecast by Region (2025-2030) & (Kilotons)
Table 107. Global Dry Age-Related Macular Degeneration Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Dry Age-Related Macular Degeneration Sales Forecast by Country (2025-2030) & (Kilotons)
Table 109. North America Dry Age-Related Macular Degeneration Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Dry Age-Related Macular Degeneration Sales Forecast by Country (2025-2030) & (Kilotons)
Table 111. Europe Dry Age-Related Macular Degeneration Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Dry Age-Related Macular Degeneration Sales Forecast by Region (2025-2030) & (Kilotons)
Table 113. Asia Pacific Dry Age-Related Macular Degeneration Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Dry Age-Related Macular Degeneration Sales Forecast by Country (2025-2030) & (Kilotons)
Table 115. South America Dry Age-Related Macular Degeneration Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Dry Age-Related Macular Degeneration Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Dry Age-Related Macular Degeneration Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Dry Age-Related Macular Degeneration Sales Forecast by Type (2025-2030) & (Kilotons)
Table 119. Global Dry Age-Related Macular Degeneration Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Dry Age-Related Macular Degeneration Price Forecast by Type (2025-2030) & (USD/Ton)
Table 121. Global Dry Age-Related Macular Degeneration Sales (Kilotons) Forecast by Application (2025-2030)
Table 122. Global Dry Age-Related Macular Degeneration Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Dry Age-Related Macular Degeneration
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Dry Age-Related Macular Degeneration Market Size (M USD), 2019-2030
Figure 5. Global Dry Age-Related Macular Degeneration Market Size (M USD) (2019-2030)
Figure 6. Global Dry Age-Related Macular Degeneration Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Dry Age-Related Macular Degeneration Market Size by Country (M USD)
Figure 11. Dry Age-Related Macular Degeneration Sales Share by Manufacturers in 2023
Figure 12. Global Dry Age-Related Macular Degeneration Revenue Share by Manufacturers in 2023
Figure 13. Dry Age-Related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Dry Age-Related Macular Degeneration Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Dry Age-Related Macular Degeneration Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Dry Age-Related Macular Degeneration Market Share by Type
Figure 18. Sales Market Share of Dry Age-Related Macular Degeneration by Type (2019-2024)
Figure 19. Sales Market Share of Dry Age-Related Macular Degeneration by Type in 2023
Figure 20. Market Size Share of Dry Age-Related Macular Degeneration by Type (2019-2024)
Figure 21. Market Size Market Share of Dry Age-Related Macular Degeneration by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Dry Age-Related Macular Degeneration Market Share by Application
Figure 24. Global Dry Age-Related Macular Degeneration Sales Market Share by Application (2019-2024)
Figure 25. Global Dry Age-Related Macular Degeneration Sales Market Share by Application in 2023
Figure 26. Global Dry Age-Related Macular Degeneration Market Share by Application (2019-2024)
Figure 27. Global Dry Age-Related Macular Degeneration Market Share by Application in 2023
Figure 28. Global Dry Age-Related Macular Degeneration Sales Growth Rate by Application (2019-2024)
Figure 29. Global Dry Age-Related Macular Degeneration Sales Market Share by Region (2019-2024)
Figure 30. North America Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Dry Age-Related Macular Degeneration Sales Market Share by Country in 2023
Figure 32. U.S. Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Dry Age-Related Macular Degeneration Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Dry Age-Related Macular Degeneration Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Dry Age-Related Macular Degeneration Sales Market Share by Country in 2023
Figure 37. Germany Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Dry Age-Related Macular Degeneration Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Dry Age-Related Macular Degeneration Sales Market Share by Region in 2023
Figure 44. China Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Dry Age-Related Macular Degeneration Sales and Growth Rate (Kilotons)
Figure 50. South America Dry Age-Related Macular Degeneration Sales Market Share by Country in 2023
Figure 51. Brazil Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Dry Age-Related Macular Degeneration Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Dry Age-Related Macular Degeneration Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Dry Age-Related Macular Degeneration Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Dry Age-Related Macular Degeneration Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Dry Age-Related Macular Degeneration Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Dry Age-Related Macular Degeneration Market Share Forecast by Type (2025-2030)
Figure 65. Global Dry Age-Related Macular Degeneration Sales Forecast by Application (2025-2030)
Figure 66. Global Dry Age-Related Macular Degeneration Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Dry Age-Related Macular Degeneration
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Dry Age-Related Macular Degeneration Market Size (M USD), 2019-2030
Figure 5. Global Dry Age-Related Macular Degeneration Market Size (M USD) (2019-2030)
Figure 6. Global Dry Age-Related Macular Degeneration Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Dry Age-Related Macular Degeneration Market Size by Country (M USD)
Figure 11. Dry Age-Related Macular Degeneration Sales Share by Manufacturers in 2023
Figure 12. Global Dry Age-Related Macular Degeneration Revenue Share by Manufacturers in 2023
Figure 13. Dry Age-Related Macular Degeneration Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Dry Age-Related Macular Degeneration Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Dry Age-Related Macular Degeneration Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Dry Age-Related Macular Degeneration Market Share by Type
Figure 18. Sales Market Share of Dry Age-Related Macular Degeneration by Type (2019-2024)
Figure 19. Sales Market Share of Dry Age-Related Macular Degeneration by Type in 2023
Figure 20. Market Size Share of Dry Age-Related Macular Degeneration by Type (2019-2024)
Figure 21. Market Size Market Share of Dry Age-Related Macular Degeneration by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Dry Age-Related Macular Degeneration Market Share by Application
Figure 24. Global Dry Age-Related Macular Degeneration Sales Market Share by Application (2019-2024)
Figure 25. Global Dry Age-Related Macular Degeneration Sales Market Share by Application in 2023
Figure 26. Global Dry Age-Related Macular Degeneration Market Share by Application (2019-2024)
Figure 27. Global Dry Age-Related Macular Degeneration Market Share by Application in 2023
Figure 28. Global Dry Age-Related Macular Degeneration Sales Growth Rate by Application (2019-2024)
Figure 29. Global Dry Age-Related Macular Degeneration Sales Market Share by Region (2019-2024)
Figure 30. North America Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Dry Age-Related Macular Degeneration Sales Market Share by Country in 2023
Figure 32. U.S. Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Dry Age-Related Macular Degeneration Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Dry Age-Related Macular Degeneration Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Dry Age-Related Macular Degeneration Sales Market Share by Country in 2023
Figure 37. Germany Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Dry Age-Related Macular Degeneration Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Dry Age-Related Macular Degeneration Sales Market Share by Region in 2023
Figure 44. China Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Dry Age-Related Macular Degeneration Sales and Growth Rate (Kilotons)
Figure 50. South America Dry Age-Related Macular Degeneration Sales Market Share by Country in 2023
Figure 51. Brazil Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Dry Age-Related Macular Degeneration Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Dry Age-Related Macular Degeneration Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Dry Age-Related Macular Degeneration Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Dry Age-Related Macular Degeneration Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Dry Age-Related Macular Degeneration Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Dry Age-Related Macular Degeneration Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Dry Age-Related Macular Degeneration Market Share Forecast by Type (2025-2030)
Figure 65. Global Dry Age-Related Macular Degeneration Sales Forecast by Application (2025-2030)
Figure 66. Global Dry Age-Related Macular Degeneration Market Share Forecast by Application (2025-2030)